Ticker brief
PRME
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
15
authors 14d
10
crowd 14d
+0.4σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-16 → 2026-08-27 · now +0.00 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @CaesarCapitalz | C | -0.81 | 3 | +0.48 |
| @hiddensmallcaps | B | -0.77 | 3 | +0.33 |
| @BioStocks | C | -3.02 | 2 | +0.28 |
| @Reformed_Trader | C | -3.02 | 1 | +0.70 |
| @SpaceSector001 | C | -4.72 | 1 | +0.40 |
| @SixSigmaCapital | B | -0.40 | 1 | +0.40 |
| @InvestmentGuru_ | C | +0.12 | 1 | +0.10 |
| @HyenukChu | C | +0.97 | 1 | +0.10 |
| @SandmanMarkets | C | -2.91 | 1 | +0.65 |
| @OptionsFlowBoss | C | · | 1 | +0.00 |
Recent signals15of 15 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @OptionsFlowBoss | +0.00 | Flags open-interest changes, with direction visible only in attached media. | · | tweet ↗ |
| 2026-08-25 | @SandmanMarkets | +0.65 | Expresses broad bullishness on biotech and names four especially attractive stocks. | · | tweet ↗ |
| 2026-08-23 | @HyenukChu | +0.10 | Presents a genome-sector basket, but the accompanying image is needed for the underlying analysis. | · | tweet ↗ |
| 2026-08-22 | @hiddensmallcaps | +0.00 | Identifies a 15-month PRME consolidation without stating breakout direction. | · | tweet ↗ |
| 2026-08-21 | @hiddensmallcaps | +0.40 | Compares gene-editing basket valuations with IONQ to argue biotech sentiment has room to improve. | · | tweet ↗ |
| 2026-08-21 | @hiddensmallcaps | +0.60 | Expects MRNA news to renew investor interest in PRME, BEAM and related biotechnology names. | · | tweet ↗ |
| 2026-08-19 | @InvestmentGuru_ | +0.10 | References three earlier-moving stocks but provides no new entry intent. | · | tweet ↗ |
| 2026-08-19 | @SixSigmaCapital | +0.40 | Offers NTLA and PRME as highly speculative bullish candidates. | · | tweet ↗ |
| 2026-08-19 | @SpaceSector001 | +0.40 | States that PRME should outperform without naming an analyst source. | · | tweet ↗ |
| 2026-08-19 | @Reformed_Trader | +0.70 | Says an AI-biotech rotation may be starting and discloses positions in four favored names. | · | tweet ↗ |
| 2026-08-19 | @BioStocks | +0.40 | BMO initiated PRME at Outperform with a $9 price target. | · | tweet ↗ |
| 2026-08-18 | @CaesarCapitalz | +0.40 | Names ABCL as a favorite and describes PRME and RXRX as promising. | · | tweet ↗ |
| 2026-08-17 | @CaesarCapitalz | +0.45 | The author hopes RXRX and PRME follow ABCL's positive trajectory as biotech attention increases. | · | tweet ↗ |
| 2026-08-17 | @CaesarCapitalz | +0.60 | Explicitly says he likes PRME at current levels. | · | tweet ↗ |
| 2026-08-16 | @BioStocks | +0.15 | Lists Google's disclosed shareholdings in biopharma companies. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.